Corbus Pharmaceuticals I... (CRBP)

AI Score

Unlock

4.84

-0.08 (-1.63%)

At close: Apr 04, 2025, 1:20 PM

Corbus Pharmaceuticals Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Cash & Equivalents	17.2M	13.72M	17M	25.01M	85.43M	31.75M	41.75M	62.54M	14.99M	12.34M	6.26M	303.02K	542.48
Short-Term Investments	131.86M	7.18M	42.19M	72.64M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	477.43K	477.43K	669.9K	n/a	n/a	n/a	50K	36.38K	n/a	n/a	n/a
Other Long-Term Assets	385K	690.23K	155.35K	46.38K	234.04K	84.97K	43.82K	40.78K	n/a	n/a	13.73K	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	2.58M	2.68M	n/a	n/a	1.33M	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	350K	-2.68M	n/a	n/a	0.00	n/a	n/a	n/a	n/a
Other Current Assets	3.91M	192.47K	192.47K	192.47K	350K	n/a	2.49M	158.99K	150K	n/a	n/a	n/a	2.50
Total Current Assets	152.98M	23.55M	60.18M	100.2M	92.07M	38.15M	44.24M	65.5M	17.4M	12.71M	6.53M	305.52K	544.98
Property-Plant & Equipment	2.52M	4.04M	5.5M	7M	9.32M	10.9M	2.71M	1.43M	435.25K	124.14K	54.04K	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	2.9M	4.73M	6.13M	7.53M	10.22M	10.99M	2.75M	1.47M	485.25K	160.51K	67.77K	n/a	n/a
Total Assets	155.88M	28.27M	66.31M	107.73M	102.29M	49.14M	46.99M	66.98M	17.89M	12.88M	6.6M	305.52K	544.98
Account Payables	4.79M	3.18M	2.17M	1.78M	7.38M	11.09M	6.35M	3.13M	3.42M	1.31M	344.16K	181.47K	49.62
Deferred Revenue	n/a	6.38M	n/a	10.09M	22.01M	n/a	1.46M	n/a	1.94M	1.59M	n/a	140.63K	n/a
Short-Term Debt	1.61M	16.21M	3.15M	3.86M	1.71M	752.66K	394.31K	332.86K	271.76K	162.02K	144.39K	306.83K	n/a
Other Current Liabilities	2.28M	8.74M	36.87K	7.51M	4.02M	3.67M	7.63M	n/a	788.51K	n/a	n/a	19.93K	227.15
Total Current Liabilities	11.82M	31.89M	12.64M	17.01M	31.9M	34.89M	18.09M	8.2M	8.9M	3.63M	738.04K	648.87K	276.78
Long-Term Debt	1.63M	n/a	15.98M	15.64M	18.03M	n/a	n/a	n/a	n/a	n/a	n/a	331.24K	466.59
Other Long-Term Liabilities	n/a	44.41K	22.2K	22.2K	n/a	n/a	1.38M	989.92K	65.72K	n/a	n/a	1.11M	-466.59
Total Long-Term Liabilities	1.63M	3.28M	20.68M	21.61M	25.12M	8.1M	1.38M	989.92K	70.36K	260.26K	n/a	1.44M	466.59
Total Liabilities	13.45M	35.18M	33.32M	38.62M	57.02M	42.98M	19.47M	9.19M	8.97M	3.89M	738.04K	2.09M	743.36
Total Debt	3.24M	20.88M	25.09M	26.59M	26.84M	9.45M	394.31K	332.86K	276.39K	162.02K	144.39K	638.08K	n/a
Common Stock	1K	442.00	417.00	12.52K	9.88K	6.47K	5.72K	5.56K	4.47K	3.76K	2.59K	696.00	0.70
Retained Earnings	-476.89M	-436.68M	-392.08M	-349.73M	-304.09M	-192.82M	-121.37M	-65.7M	-33.28M	-13.28M	-4.43M	-1.89M	-1.28K
Comprehensive Income	35K	-1.56K	-126.09K	-62.45K	n/a	n/a	-666.58K	-363.89K	-108.24K	-54.35K	-10.4K	-1.11M	n/a
Shareholders Equity	142.43M	-6.9M	32.99M	69.11M	45.27M	6.16M	27.52M	57.78M	8.92M	8.99M	5.86M	-1.78M	-198.38
Total Investments	131.86M	7.18M	42.19M	72.64M	669.9K	n/a	n/a	n/a	50K	36.38K	n/a	n/a	n/a